Dimension | Control | DMR | VEGF | ||||||
---|---|---|---|---|---|---|---|---|---|
Baseline | 3 mo | Baseline | 3 mo | Baseline | 3 mo | ||||
RAND-36 | |||||||||
Physical functioning | 23 | 34* | 36 | 58* | 23 | 44* | |||
Social functioning | 40 | 40 | 57 | 65 | 25 | 52* | |||
Role limitation physical | 0 | 0 | 8 | 35* | 4 | 25 | |||
Role limitation emotional | 20 | 0 | 50 | 78 | 29 | 43 | |||
Mental health | 51 | 41 | 59 | 66 | 49 | 60* | |||
Vitality | 34 | 41 | 38 | 55* | 24 | 46* | |||
Bodily pain | 29 | 33 | 40 | 61* | 26 | 57* | |||
General health perception | 27 | 31 | 31 | 47* | 26 | 36 | |||
Perceived change in health | 20 | 20 | 33 | 69 | 13 | 63* | |||
MPVH, feelings of disability | 34 | 35 | 34 | 31* | 35 | 30* | |||
MFI, fatigue overall score | 77 | 75 | 71 | 58* | 79 | 70* |
↵* Large changes in dimension according to effect sizes proposed by Cohen (19,20) (≥0.80) are indicated.